Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients.

NCT07081373 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

408

Enrollment

OTHER

Sponsor class

Conditions

Anal Fistula

Interventions

DRUG: A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]